• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by IMAC Holdings Inc. (Amendment)

    1/19/22 2:43:18 PM ET
    $IMAC
    Medical Specialities
    Health Care
    Get the next $IMAC alert in real time by email
    SC 13G/A 1 ea154205-13ga1alpha_imachold.htm AMENDMENT NO. 1 TO SCHEDULE 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    SCHEDULE 13G/A

     

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (AMENDMENT NO. 1)

     

    IMAC HOLDINGS, INC. 

     

    (Name of Issuer)

     

    COMMON STOCK, PAR VALUE $0.001 

     

    (Title of Class of Securities)

     

    44967K104 

     

    (CUSIP Number)

     

    December 31, 2021 

     

    (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(c)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    (Continued on following page(s)

     

    Page 1 of 5 Pages

     

     

     

     

     

     

    CUSIP No. 44967K104   13G Page 2 of 5 Pages

     

    1. NAMES OF REPORTING PERSON
      S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
       
      Alpha Capital Anstalt
    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:

       
      (a) ☐
      (b) ☐
    3. SEC USE ONLY
       
    4. CITIZENSHIP OR PLACE OF ORGANIZATION
       
      Liechtenstein
    5. SOLE VOTING POWER, NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON – 1,958,871 Shares (1)
       
    6. SHARED VOTING POWER - None
     
    7. SOLE DISPOSITIVE POWER – 1,958,871 Shares (1)
     
    8. SHARED DISPOSITIVE POWER – None
     
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON –
       
      1,958,871 Shares (1)
    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

      ☐    
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
       
      7.474%
    12. TYPE OF REPORTING PERSON
       
      CO

     

    (1)Based on 26,208,167 shares outstanding as of November 10, 2021 as reported on Form 10-Q filed November 10, 2021 for the quarterly period ended September 30, 2021.

     

     

     

     

    CUSIP No. 44967K104   13G Page 3 of 5 Pages

     

    ITEM 1 (a) NAME OF ISSUER: IMAC Holdings, Inc., a Delaware corporation

     

    ITEM 1 (b) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:

     

    1605 Westgate Circle, Brentwood, Tennessee 37027

     

    ITEM 2 (a) NAME OF PERSON FILING: Alpha Capital Anstalt

     

    ITEM 2 (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

     

    Altenbach 8, FL-9490 Vaduz, Liechtenstein

     

    ITEM 2 (c) CITIZENSHIP: Liechtenstein

     

    ITEM 2 (d) TITLE OF CLASS OF SECURITIES: Common Stock, par value $0.001

     

    ITEM 2 (e) CUSIP NUMBER: 44967K104

     

    ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B): Not applicable

     

    ITEM 4 OWNERSHIP

     

    (a) AMOUNT BENEFICIALLY OWNED: 1,958,871 Shares (1)

     

    (b) PERCENT OF CLASS: 7.474%

     

    (c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:

     

    (i) SOLE POWER TO VOTE OR DIRECT THE VOTE

     

    1,958,871 Shares (1)

     

    (ii) SHARED POWER TO VOTE OR DIRECT THE VOTE

     

    0 Shares

     

    (iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

     

    1,958,871 Shares (1)

     

    (iv) SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

     

    0 Shares

     

     

     

     

    CUSIP No. 44967K104   13G Page 4 of 5 Pages

     

    ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

     

    Not applicable

     

    ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

     

    Not applicable

     

    ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

     

    Not applicable

     

    ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP

     

    Not applicable

     

    ITEM 9 NOTICE OF DISSOLUTION OF GROUP

     

    Not applicable

     

     

     

     

    CUSIP No. 44967K104   13G Page 5 of 5 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

     

    January 19, 2022

      (Date)
       
      /s/ Konrad Ackermann
      (Signature)
       
      Konrad Ackermann, Director
      (Name/Title)

     

     

     

     

    Get the next $IMAC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IMAC

    DatePrice TargetRatingAnalyst
    8/19/2021$2.35 → $1.75Buy → Neutral
    National Alliance Securities
    More analyst ratings

    $IMAC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    IMAC Holdings downgraded by National Alliance Securities with a new price target

    National Alliance Securities downgraded IMAC Holdings from Buy to Neutral and set a new price target of $1.75 from $2.35 previously

    8/19/21 11:40:11 AM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Sucoff Cary was granted 100,000 shares, increasing direct ownership by 100% to 200,000 units

    4 - IMAC Holdings, Inc. (0001729944) (Issuer)

    10/20/22 4:30:33 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form 4: Evans Maurice E. was granted 100,000 shares, increasing direct ownership by 89% to 212,420 units

    4 - IMAC Holdings, Inc. (0001729944) (Issuer)

    10/20/22 4:30:36 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form 4: Pruitt Michael D was granted 100,000 shares and covered exercise/tax liability with 37,000 shares, increasing direct ownership by 62% to 164,250 units

    4 - IMAC Holdings, Inc. (0001729944) (Issuer)

    10/20/22 4:30:38 PM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    SEC Filings

    View All

    SEC Form 10-Q filed by IMAC Holdings Inc.

    10-Q - IMAC Holdings, Inc. (0001729944) (Filer)

    11/14/22 5:25:58 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form EFFECT filed by IMAC Holdings Inc.

    EFFECT - IMAC Holdings, Inc. (0001729944) (Filer)

    10/14/22 12:15:29 AM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form S-3/A filed by IMAC Holdings Inc. (Amendment)

    S-3/A - IMAC Holdings, Inc. (0001729944) (Filer)

    10/7/22 5:01:30 PM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    IMAC Holdings, Inc. Announces NASDAQ Ticker Symbol Change from "IMAC" to "BACK"

    BRENTWOOD, Tenn., Aug. 03, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), will change its ticker symbol on the NASDAQ Stock Exchange from "IMAC" to "BACK" at the open of market trading on Monday, August 8, 2022. "IMAC Holdings has developed a continuum of care for optimal spinal health, from the chiropractic wellness centers at the BackSpace to the IMAC Regeneration Centers' medical doctors, nurse practitioners, and physical therapists delivering advanced and innovative medical intervention," said Jeffrey Ervin, IMAC's Chief Executive Officer. "The spine is your body's central support structure and we recognize its importance for your overall health

    8/3/22 9:22:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    IMAC Holdings Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

    BRENTWOOD, Tenn., July 26, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced that its board of directors has initiated an exploration of strategic alternatives. As part of this process, the board will consider a wide range of options for the company including, among other things, a potential merger, spin-off, sale, or other strategic transaction for one or more of its key business units or assets. "As our company continues to expand into complementary revenue streams, we believe

    7/26/22 9:15:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    The Back Company demonstrates strong Q2 growth

    The Back Space sequential quarter traffic increased over 100% BRENTWOOD, Tenn., June 30, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), today announces significant traffic growth for The Back Company. The Back Space retail chiropractic centers, located in select Walmart stores, generated over 100% visit growth compared to the first quarter. "Our team's effort is evident as we continue to improve systems to support our doctors that delivered over 6,500 visits this calendar quarter," said Jeff Ervin, Chief Executive Officer of IMAC. "The Back Space growth for the second quarter will be a springboard to material revenue during the second half of the y

    6/30/22 9:20:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Leadership Updates

    Live Leadership Updates

    View All

    IMAC Holdings Appoints Sheri Gardzina as Secretary, Chief Financial Officer

    BRENTWOOD, Tenn., Jan. 07, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces the appointment of Sheri Gardzina, CPA as its Chief Financial Officer. To date, Ms. Gardzina has served as CFO in an interim capacity. “Sheri has been an excellent addition to our management team since joining the company and we are pleased to have her as our permanent Chief Financial Officer. She brings a wealth of financial and accounting experience to the company and I am excited to continue worki

    1/7/21 8:00:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by IMAC Holdings Inc.

    SC 13G - IMAC Holdings, Inc. (0001729944) (Subject)

    1/23/23 10:00:08 AM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by IMAC Holdings Inc. (Amendment)

    SC 13G/A - IMAC Holdings, Inc. (0001729944) (Subject)

    9/9/22 4:05:20 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by IMAC Holdings Inc.

    SC 13G - IMAC Holdings, Inc. (0001729944) (Subject)

    5/18/22 1:40:55 PM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Financials

    Live finance-specific insights

    View All

    IMAC Holdings Reports Third Quarter 2021 Financial Results and Provides Corporate Update

    BRENTWOOD, Tenn., Nov. 10, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (NASDAQ:IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces financial results for the third quarter ended September 30, 2021. Financial Highlights from 3Q 2021 (all comparisons are with the quarter ended September 30, 2020, unless otherwise indicated): Total revenue was $3.49 million, compared with $3.48 millionTotal patient visits at IMAC Centers were up 10% to 43,451, compared to 39,345Net loss was $1.7 million, or a loss of $0.07 per share, compared with a net

    11/10/21 4:48:15 PM ET
    $IMAC
    Medical Specialities
    Health Care

    IMAC Holdings Reports Second Quarter 2021 Financial Results

    IMAC reports 36% increase in revenues and 70% increase in patient visits as it invests in value-generating assets BRENTWOOD, Tenn., Aug. 12, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (NASDAQ:IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces financial results for the second quarter ended June 30, 2021. Financial Highlights from 2Q 2021 (all comparisons are for the quarter ended June 30, 2020, unless otherwise indicated): Total revenue was $3.4 million, compared with $2.5 million, an increase o

    8/12/21 9:00:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    IMAC Holdings Acquires Active Medical Center in Southwestern Chicago Suburb

    Naperville, Ill. purchase to be rebranded Mike Ditka IMAC Regeneration Center BRENTWOOD, Tenn., June 25, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces the Company's expansion in the Chicago market with the asset purchase of Active Medical Center's Naperville, Illinois location, effective Monday, June 28. Active Medical Center is a medical clinic that addresses a wide variety of orthopedic treatments for various conditions through a combination of medical and physical rehabilitatio

    6/25/21 8:00:00 AM ET
    $IMAC
    Medical Specialities
    Health Care